pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: oceanside pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler oceanside pharmaceuticals
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

pyridostigmine bromide 60 mg/5mL

Manufacturer
Oceanside Pharmaceuticals

Identifiers & Regulatory

Product NDC 68682-307
Product ID 68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA015193
Listing Expiration 2026-12-31
Marketing Start 2019-07-01

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68682307
Hyphenated Format 68682-307

Supplemental Identifiers

RxCUI
903843
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number NDA015193 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (68682-307-05)
source: ndc

Packages (1)

Ingredients (1)

pyridostigmine bromide (60 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "dea0cb1f-7ec8-4f54-968f-8f095fa8ac95", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["970a0191-693c-480b-aeff-9f8956936159"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (68682-307-05)", "package_ndc": "68682-307-05", "marketing_start_date": "20190701"}], "brand_name": "pyridostigmine bromide", "product_id": "68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "68682-307", "generic_name": "pyridostigmine bromide", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pyridostigmine bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "NDA015193", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20190701", "listing_expiration_date": "20261231"}